Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2012

Nov 28, 2012

30718_dirs_2012-11-28_3b4a08a9-f37c-419e-9b9b-8511508587a1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2012-10-26

Reporting Person: OCONNELL HOWARD V (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-10-26 Common Stock M 5000 $37.1 Acquired 95639 Indirect
2012-10-26 Common Stock S 8000 $71.81 Disposed 87639 Indirect
2012-10-27 Common Stock G 20000 $71.65 Disposed 67639 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-10-26 Stock Option $37.1 M 5000 Disposed 2014-10-20 Common Stock (5000) Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $66.9 2022-10-24 Common Stock (5000) 5000 Direct
Stock Option $70.35 2021-10-26 Common Stock (5000) 5000 Direct
Stock Option $61.46 2020-10-27 Common Stock (5000) 5000 Direct
Stock Option $63.03 2019-10-28 Common Stock (5000) 5000 Indirect
Stock Option $65.47 2018-10-22 Common Stock (5000) 5000 Indirect
Stock Option $66.59 2017-10-24 Common Stock (5000) 5000 Indirect
Stock Option $56.17 2016-10-25 Common Stock (5000) 5000 Indirect
Stock Option $54.68 2015-10-26 Common Stock (5000) 5000 Indirect